Candel Therapeutics Inc
CADLLatest QuantConomy context for CADL: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Candel Therapeutics Inc
QuantConomy has a structured record for CADL. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- CADL
- Name
- Candel Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq
Recent signals for CADL
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| executive trade | bearish | 31 | Jul 1, 08:28 PM | Barone Francesca (Chief Scientific Officer) sold CADL shares ($0.24M) - 23,447 shares - [very weak bearish signal] |
| operating income change | very bullish | 76 | May 14, 12:00 AM | CADL (Q1 2026, operating income): grew 66.3% (-$48.27M → -$16.28M). [sequential period basis, very bullish signal] |
| eps change | very bullish | 76 | May 14, 12:00 AM | CADL (Q1 2026, diluted eps): EPS grew 80.6% ($-0.72 → $-0.14). [sequential period basis, very bullish signal] |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| CADL | NASDAQ | fmp | Candel Therapeutics, Inc. |
| CADL | NASDAQ | alpaca | Candel Therapeutics, Inc. Common Stock |
| CADL | NASDAQ | alphavantage | Candel Therapeutics Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 6, 2026 | Sims Mark E. | Chief Commercial Officer | grant | 285,000 | — | — | 4 on EDGAR |
| Jun 30, 2026 | Manning Paul B | Director | grant | 2,199 | $8.64 | $18,997 | 4 on EDGAR |
| Jun 30, 2026 | Loggia Nicoletta | Director | grant | 381 | $8.64 | $3,291 | 4 on EDGAR |
| Jun 30, 2026 | PAPA JOSEPH C | Director | grant | 1,331 | $8.64 | $11,499 | 4 on EDGAR |
| Jun 29, 2026 | Barone Francesca | Chief Scientific Officer | sale | 23,447 | $10.06 | $235,769 | 4 on EDGAR |
| Jun 29, 2026 | Tyagarajan Seshu | Chief Technology Officer | sale | 7,000 | $10.02 | $70,151 | 4 on EDGAR |
| Jun 23, 2026 | Nabel Gary J. | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Gaeta Renee | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | PAPA JOSEPH C | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Benz Edward J. JR | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Manning Paul B | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Martell Christopher | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Nguyen Diem | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Loggia Nicoletta | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Jun 23, 2026 | Radhakrishnan Maha | Director | grant | 32,000 | — | — | 4 on EDGAR |
| Mar 31, 2026 | Manning Paul B | Director | grant | 4,618 | $4.11 | $18,998 | 4 on EDGAR |
| Mar 31, 2026 | Loggia Nicoletta | Director | grant | 779 | $4.11 | $3,205 | 4 on EDGAR |
| Mar 31, 2026 | PAPA JOSEPH C | Director | grant | 2,795 | $4.11 | $11,499 | 4 on EDGAR |
| Feb 23, 2026 | Manning Paul B | Director | purchase | 550,458 | $5.45 | $2,999,996 | 4 on EDGAR |
| Jan 26, 2026 | Tyagarajan Seshu | Chief Technology Officer | grant | 154,000 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query CADL context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access